Intuitive Surgical, Inc. (ISRG)

$374.96

-0.05

(-0.01%)▲

Live

star icon

Intuitive Surgical, Inc. is a medical technology company that develops and manufactures robotic-assisted surgical systems and instruments.

Insights on Intuitive Surgical, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.92B → 1.89B (in $), with an average decrease of 2.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 606.2M → 544.9M (in $), with an average decrease of 10.1% per quarter

Performance

  • $367.79
    $375.37
    $374.96
    downward going graph

    1.91%

    Downside

    Day's Volatility :2.02%

    Upside

    0.11%

    downward going graph
  • $254.85
    $403.76
    $374.96
    downward going graph

    32.03%

    Downside

    52 Weeks Volatility :36.88%

    Upside

    7.13%

    downward going graph

Returns

PeriodIntuitive Surgical, Inc.Sector (Health Care)Index (NASDAQ Composite)
3 Months
0.01%
1.7%
1.3%
6 Months
40.66%
11.3%
22.6%
1 Year
27.13%
5.4%
33.2%
3 Years
29.92%
13.9%
12.1%

Highlights

Market Capitalization
133.8B
Book Value
$39.37
Earnings Per Share (EPS)
5.54
PE Ratio
68.07
PEG Ratio
7.13
Wall Street Target Price
418.24
Profit Margin
27.16%
Operating Margin TTM
24.83%
Return On Assets TTM
8.0%
Return On Equity TTM
15.82%
Revenue TTM
7.3B
Revenue Per Share TTM
20.79
Quarterly Revenue Growth YOY
11.5%
Gross Profit TTM
4.2B
EBITDA
2.3B
Diluted Eps TTM
5.54
Quarterly Earnings Growth YOY
0.51
EPS Estimate Current Year
6.28
EPS Estimate Next Year
7.35
EPS Estimate Current Quarter
1.41
EPS Estimate Next Quarter
1.56

Analyst Recommendation

Buy
    71%Buy
    28%Hold
    0
    0%Sell
Based on 35 Wall street analysts offering stock ratings for Intuitive Surgical, Inc.(by analysts ranked 0 to 5 stars)
Based on 35 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
25
23
23
Hold
10
10
11
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 11.54%

Current $374.96
Target $418.24

Company Financials

FY18Y/Y Change
Revenue
3.7B
↑ 19.03%
Net Income
1.1B
↑ 70.89%
Net Profit Margin
30.29%
↑ 9.2%
FY19Y/Y Change
Revenue
4.5B
↑ 20.25%
Net Income
1.4B
↑ 22.29%
Net Profit Margin
30.8%
↑ 0.51%
FY20Y/Y Change
Revenue
4.4B
↓ 2.68%
Net Income
1.1B
↓ 23.11%
Net Profit Margin
24.33%
↓ 6.47%
FY21Y/Y Change
Revenue
5.7B
↑ 31.01%
Net Income
1.7B
↑ 60.72%
Net Profit Margin
29.85%
↑ 5.52%
FY22Y/Y Change
Revenue
6.2B
↑ 8.97%
Net Income
1.3B
↓ 22.43%
Net Profit Margin
21.25%
↓ 8.6%
FY23Y/Y Change
Revenue
7.1B
↑ 14.49%
Net Income
1.8B
↑ 35.98%
Net Profit Margin
25.24%
↑ 3.99%
Q4 FY22Q/Q Change
Revenue
1.7B
↑ 6.27%
Net Income
324.9M
↑ 0.28%
Net Profit Margin
19.63%
↓ 1.17%
Q1 FY23Q/Q Change
Revenue
1.7B
↑ 2.49%
Net Income
355.3M
↑ 9.36%
Net Profit Margin
20.95%
↑ 1.32%
Q2 FY23Q/Q Change
Revenue
1.8B
↑ 3.52%
Net Income
420.8M
↑ 18.44%
Net Profit Margin
23.96%
↑ 3.01%
Q3 FY23Q/Q Change
Revenue
1.7B
↓ 0.69%
Net Income
415.7M
↓ 1.21%
Net Profit Margin
23.84%
↓ 0.12%
Q4 FY23Q/Q Change
Revenue
1.9B
↑ 10.59%
Net Income
606.2M
↑ 45.83%
Net Profit Margin
31.44%
↑ 7.6%
Q1 FY24Q/Q Change
Revenue
1.9B
↓ 1.96%
Net Income
544.9M
↓ 10.11%
Net Profit Margin
28.82%
↓ 2.62%
FY18Y/Y Change
Total Assets
7.8B
↑ 36.27%
Total Liabilities
1.2B
↑ 12.41%
FY19Y/Y Change
Total Assets
9.7B
↑ 24.04%
Total Liabilities
1.4B
↑ 24.96%
FY20Y/Y Change
Total Assets
11.2B
↑ 14.75%
Total Liabilities
1.4B
↓ 2.67%
FY21Y/Y Change
Total Assets
13.6B
↑ 21.36%
Total Liabilities
1.6B
↑ 13.74%
FY22Y/Y Change
Total Assets
13.0B
↓ 4.29%
Total Liabilities
1.9B
↑ 16.08%
FY23Y/Y Change
Total Assets
15.4B
↑ 19.02%
Total Liabilities
2.0B
↑ 9.82%
Q4 FY22Q/Q Change
Total Assets
13.0B
↓ 2.16%
Total Liabilities
1.9B
↑ 10.35%
Q1 FY23Q/Q Change
Total Assets
13.1B
↑ 0.61%
Total Liabilities
1.8B
↓ 5.5%
Q2 FY23Q/Q Change
Total Assets
13.9B
↑ 6.51%
Total Liabilities
1.9B
↑ 10.49%
Q3 FY23Q/Q Change
Total Assets
14.7B
↑ 5.82%
Total Liabilities
2.1B
↑ 7.49%
Q4 FY23Q/Q Change
Total Assets
15.4B
↑ 4.95%
Total Liabilities
2.0B
↓ 2.15%
Q1 FY24Q/Q Change
Total Assets
15.8B
↑ 2.5%
Total Liabilities
1.8B
↓ 12.85%
FY18Y/Y Change
Operating Cash Flow
1.2B
↑ 2.25%
Investing Cash Flow
-1.0B
↓ 377.16%
Financing Cash Flow
126.3M
↓ 106.6%
FY19Y/Y Change
Operating Cash Flow
1.6B
↑ 36.65%
Investing Cash Flow
-1.2B
↑ 9.98%
Financing Cash Flow
-168.4M
↓ 233.33%
FY20Y/Y Change
Operating Cash Flow
1.5B
↓ 7.1%
Investing Cash Flow
-940.6M
↓ 18.52%
Financing Cash Flow
-85.7M
↓ 49.11%
FY21Y/Y Change
Operating Cash Flow
2.1B
↑ 40.72%
Investing Cash Flow
-2.5B
↑ 161.69%
Financing Cash Flow
43.0M
↓ 150.18%
FY22Y/Y Change
Operating Cash Flow
1.5B
↓ 28.65%
Investing Cash Flow
1.4B
↓ 155.69%
Financing Cash Flow
-2.6B
↓ 6082.09%
Q4 FY22Q/Q Change
Operating Cash Flow
437.9M
↑ 14.27%
Investing Cash Flow
574.8M
↑ 5.56%
Financing Cash Flow
-963.5M
↑ 3.96%
Q1 FY23Q/Q Change
Operating Cash Flow
371.4M
↓ 15.19%
Investing Cash Flow
573.1M
↓ 0.3%
Financing Cash Flow
-381.2M
↓ 60.44%
Q2 FY23Q/Q Change
Operating Cash Flow
665.7M
↑ 79.24%
Investing Cash Flow
557.6M
↓ 2.7%
Financing Cash Flow
63.3M
↓ 116.61%
Q3 FY23Q/Q Change
Operating Cash Flow
548.4M
↓ 17.62%
Investing Cash Flow
-446.6M
↓ 180.09%
Financing Cash Flow
61.8M
↓ 2.37%

Technicals Summary

Sell

Neutral

Buy

Intuitive Surgical, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-4.26%
40.66%
27.13%
29.92%
117.28%
Resmed Inc.
Resmed Inc.
-4.93%
30.8%
-18.9%
-12.86%
79.74%
Becton, Dickinson And Company
Becton, Dickinson And Company
-3.24%
-8.51%
-10.39%
-9.17%
-1.52%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-0.68%
7.75%
8.05%
19.64%
215.5%
Alcon Ag
Alcon Ag
-4.1%
12.21%
10.64%
4.52%
37.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
68.07
68.07
7.13
6.28
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
30.5
30.5
1.75
7.4
0.22
0.11
0.01
30.47
Becton, Dickinson And Company
Becton, Dickinson And Company
53.75
53.75
1.34
12.95
0.05
0.03
0.02
87.68
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
49.52
49.52
6.72
7.62
0.21
0.12
0.0
39.2
Alcon Ag
Alcon Ag
41.2
41.2
4.59
3.06
0.05
0.02
0.0
41.81
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$133.8B
117.28%
68.07
27.16%
Resmed Inc.
Resmed Inc.
Buy
$27.1B
79.74%
30.5
19.77%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.7B
-1.52%
53.75
6.44%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$28.6B
215.5%
49.52
20.12%
Alcon Ag
Alcon Ag
Buy
$39.9B
37.47%
41.2
10.3%

Institutional Holdings

  • Vanguard Group Inc

    8.56%

  • BlackRock Inc

    8.24%

  • T. Rowe Price Associates, Inc.

    4.79%

  • State Street Corporation

    4.22%

  • FMR Inc

    2.13%

  • AllianceBernstein L.P.

    2.06%

Company Information

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500.

Organization
Intuitive Surgical, Inc.
Employees
13676
CEO
Dr. Gary S. Guthart Ph.D.
Industry
Health Technology

Discover More

FAQs